Halozyme Therapeutics, Inc. (HALO)
68.32
-0.20
(-0.29%)
USD |
NASDAQ |
May 22, 16:00
68.30
-0.02
(-0.03%)
After-Hours: 20:00
Halozyme Therapeutics Price : 68.32 for May 22, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vertex Pharmaceuticals, Inc. | 434.52 |
| Agenus, Inc. | 3.11 |
| Inovio Pharmaceuticals, Inc. | 1.35 |
| Curis, Inc. | 0.5012 |
| Plus Therapeutics, Inc. | 6.59 |
Price Related Metrics
| PE Ratio | 24.57 |
| PS Ratio | 5.515 |
| Price to Book Value | 36.90 |
| Price to Free Cash Flow | 12.46 |
| Earnings Yield | 4.07% |
| Market Cap | 8.104B |
| Operating PE Ratio | 9.681 |
| Normalized PE Ratio | 14.00 |